Highly concentrated solutions present different challenges
The FDAs Pharmaceutical Compounding Advisory Committee (PCAC) voted to add six of seven peptides to the 503A Bulk Drug Substance List, despite FDA scientists recommending against all of them because of limited evidence of their safety and effectiveness
Functional milestones Functional improvements often tell you more than pain scores alone: Walking distance without symptom increase Sitting tolerance (minutes before symptoms worsen) Ability to perform previously limited activities Sleep quality (reduced nighttime symptoms indicate improvement) Medication usage (decreasing NSAID use is a positive sign) When to adjust the protocol If there is no improvement after 3 to 4 weeks on a BPC-157 only protocol, consider adding TB-500 for systemic support
Consider protocol intensity
Lipid peroxidation up-regulates BACE1 expression in vivo : a possible early event of amyloidogenesis in Alzheimer's disease
As mentioned, ingredients that hydrate and strengthen the skin barrier significantly reduce skin irritation and further boost the benefit, so it is always a good start to find products formulated with these actives to reduce the need for layering, making it simple